ES2146614T3 - Derivados de azepina, produccion de los mismos y su utilizacion como ligandos del receptor sigma. - Google Patents

Derivados de azepina, produccion de los mismos y su utilizacion como ligandos del receptor sigma.

Info

Publication number
ES2146614T3
ES2146614T3 ES93919635T ES93919635T ES2146614T3 ES 2146614 T3 ES2146614 T3 ES 2146614T3 ES 93919635 T ES93919635 T ES 93919635T ES 93919635 T ES93919635 T ES 93919635T ES 2146614 T3 ES2146614 T3 ES 2146614T3
Authority
ES
Spain
Prior art keywords
same
receiver
azepina
delta
ligands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93919635T
Other languages
English (en)
Inventor
Nobuyuki Takahashi
Daisuke Mochizuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Industry Co Ltd, Asahi Kasei Kogyo KK filed Critical Asahi Chemical Industry Co Ltd
Application granted granted Critical
Publication of ES2146614T3 publication Critical patent/ES2146614T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/24—Camphidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

UN DERIVADO DE AZEPINA REPRESENTADO POR LA FORMULA GENERAL (1) O UNA SAL NO TOXICA DEL MISMO, UN PROCESO PARA PRODUCIR EL MISMO, Y UN AGENTE TERAPEUTICO QUE CONTIENE EL MISMO COMO INGREDIENTE ACTIVO PARA TRATAR ENFERMEDADES RELACIONADAS AL RECEPTOR - DELTA, EN DONDE R REPRESENTA UN GRUPO REPRESENTADO POR LA FORMULA GENERAL (2) (EN DONDE R1 REPRESENTA HIDROGENO, ALQUILO INFERIOR, ALCOXILO INFERIOR, HIDROXI, HALOGENO O FENILO OPCIONALMENTE SUSTITUIDO, Y N REPRESENTA 0 O 1), CICLOALQUILO C5 C8 QUE PUEDE ESTAR SUSTITUIDO POR ALQUILO INFERIOR, NORBORNILO, BICICLO [3,3,1] NONILO, NAFTILO, 1,3BENZODIOXOLIL, PIRIDILO O TIENILO; M REPRESENTA UN NUMERO ENTERO DE 0 A 4; C* REPRESENTA UN ATOMO DE CARBONO ASIMETRICO. EL COMPUESTO (1) Y LA SAL NO TOXICA DEL MISMO TIENEN UNA ELEVADA AFINIDAD PARA EL RECEPTOR DELTA PERO APENAS NINGUNA AFINIDAD PARA OTROS RECEPTORES, SIENDO UTILIZADO ASI PARA TRATAR ENFERMEDADES RELACIONADAS CON EL RECEPTOR DELTA, TALES COMO LA ESQUIZOFRENIA.
ES93919635T 1992-09-18 1993-09-09 Derivados de azepina, produccion de los mismos y su utilizacion como ligandos del receptor sigma. Expired - Lifetime ES2146614T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25015892 1992-09-18
JP26770292 1992-10-06

Publications (1)

Publication Number Publication Date
ES2146614T3 true ES2146614T3 (es) 2000-08-16

Family

ID=26539665

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93919635T Expired - Lifetime ES2146614T3 (es) 1992-09-18 1993-09-09 Derivados de azepina, produccion de los mismos y su utilizacion como ligandos del receptor sigma.

Country Status (7)

Country Link
EP (1) EP0661271B1 (es)
KR (2) KR950703535A (es)
CA (1) CA2144974C (es)
DE (1) DE69328490T2 (es)
ES (1) ES2146614T3 (es)
HK (1) HK1000708A1 (es)
WO (1) WO1994006773A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650406A (en) * 1994-04-18 1997-07-22 Asahi Kasei Kogyo Kabushiki Kaisha Adamantane derivative, process for producing the same, and use thereof
EP4532668A1 (en) * 2022-05-31 2025-04-09 Symrise AG Ethyl 2-cyclooctylacetate as a fragrance

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL125434C (es) * 1961-11-20 1900-01-01
US3328390A (en) * 1962-02-27 1967-06-27 Tri Kem Corp Certain azabicycloalkane compounds
GB1053085A (es) * 1964-03-26
DE2341925A1 (de) * 1973-08-20 1975-03-06 Thomae Gmbh Dr K Neue pyrimidinderivate und verfahren zu ihrer herstellung
ZA791262B (en) * 1978-04-12 1980-07-30 American Cyanamid Co Novel anti-arthritic 2,4,6-tris.(substituted-amino)-striazines
US4945097A (en) * 1987-10-23 1990-07-31 G. D. Searle & Co. Aryl-cycloalkyl-alkanolamines for treatment of neurotoxic injury

Also Published As

Publication number Publication date
EP0661271B1 (en) 2000-04-26
EP0661271A4 (en) 1995-04-21
CA2144974C (en) 2000-03-28
KR950703535A (ko) 1995-09-20
DE69328490D1 (de) 2000-05-31
EP0661271A1 (en) 1995-07-05
KR0147732B1 (ko) 1998-08-17
DE69328490T2 (de) 2001-01-25
HK1000708A1 (en) 2000-10-20
CA2144974A1 (en) 1994-03-31
WO1994006773A1 (fr) 1994-03-31

Similar Documents

Publication Publication Date Title
MX2021011647A (es) Moduladores del receptor x4 de proteina g relacionado con mas y productos y metodos relacionados.
GB2210879B (en) 4h-1-benzopyran-4-one derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
ES2124612T3 (es) Dihidrodibenzo(b,f)azepinas, substituidas, metodo para su preparacion, su utilizacion en el tratamiento de diversos trastornos del sistema nervioso central y composiciones farmaceuticas que las contienen.
HUT58036A (en) Process for producing new substituted aminomethyl tetraline derivatives and their heterocyclic analogs, as well as pharmaceutical compositions comprising such compounds
ES2095566T3 (es) Suspension farmaceutica acuosa para agentes activos farmaceuticos.
UY28132A1 (es) Derivados de pirrolopirimidina
AR001470A1 (es) Agente para el control de enfermedades de agricultura y horticultura y un método para controlar dichas enfermedades.
BG102259A (en) Compostions with controlled paroxetine release
ES2052881T3 (es) Agentes reductores de la presion sanguinea.
EA200300519A1 (ru) Соединения производных бензотиофена, способ их получения и применения
UA41869C2 (uk) Похідні етаноламіну, спосіб їх одержання, фармацевтична композиція, спосіб лікування
ES2084339T3 (es) Tetrahidropiridinas e hidroxipiperidinas sustituidas utiles como agentes para el sistema nervioso central.
DE69229339D1 (de) Kristallines tiagabinehydrochlorid-monohydrat, seine herstellung und verwendung
ATE325610T1 (de) Xanthinderivative zur behandlung von hirnischämie
ES2153019T3 (es) Derivados de benzo-dioxano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2126579T3 (es) Comprimidos de dispersion solida que contienen derivados de 1,4-dihidropiridina y procedimiento para su preparacion.
JPS52286A (en) Method of preparing 1-(3-phenylpropyl)-4-acylpiperazine derivatives
ES2146614T3 (es) Derivados de azepina, produccion de los mismos y su utilizacion como ligandos del receptor sigma.
NO922531L (no) Middel for forhindring av og behandling av fiskesykdommer
TW353658B (en) Substituted tetrahydroisoquinoline compounds, pharmaceutical compositions containing them, and processes for their preparation
HUT61655A (en) Selective herbicide compositions containing salicylic acid derivatives as active components and process for producing the active components
NO179009C (no) Analogifremgangsmåte for fremstilling av salter av L-alfa-glyserofosforyl-D-myo-inositol
ES2157498T3 (es) Derivados de triazol o sus sales.
NO973341L (no) Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for vasodilatorisk behandling eller profylakse
EP0769496A4 (en) 2,3-DIHYDROBENZOFURAN DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 661271

Country of ref document: ES